Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.
about
Advances in aluminum hydroxide-based adjuvant research and its mechanismUse of praziquantel as an adjuvant enhances protection and Tc-17 responses to killed H5N1 virus vaccine in miceThe Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in MiceCAF01 potentiates immune responses and efficacy of an inactivated influenza vaccine in ferretsA synthetic adjuvant to enhance and expand immune responses to influenza vaccinesPreclinical evaluation of Vaxfectin-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccinesMolecular and cellular signatures of human vaccine adjuvants.Development of a vaccine against pandemic influenza viruses: current status and perspectives.Emulsion-based adjuvants for influenza vaccines.An adjuvant for the induction of potent, protective humoral responses to an H5N1 influenza virus vaccine with antigen-sparing effect in mice.MF59 adjuvant: the best insurance against influenza strain diversity.New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges.Protection against intestinal amebiasis by a recombinant vaccine is transferable by T cells and mediated by gamma interferon.The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen.A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challengeMonocyte-derived dendritic cells promote T follicular helper cell differentiation.The TLR2 Binding Neisserial Porin PorB Enhances Antigen Presenting Cell Trafficking and Cross-presentation.In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants.Recent progress in adjuvant discovery for peptide-based subunit vaccinesVaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration.Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes.Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59.The two-component adjuvant IC31® boosts type i interferon production of human monocyte-derived dendritic cells via ligation of endosomal TLRs.Differential effects of viral vectors on migratory afferent lymph dendritic cells in vitro predict enhanced immunogenicity in vivo.Vaccine Potentiation by Combination AdjuvantsImmunosenescence and Challenges of Vaccination against Influenza in the Aging Population.Adjuvants for Leishmania vaccines: from models to clinical application.Intranasal Immunization Using Mannatide as a Novel Adjuvant for an Inactivated Influenza Vaccine and Its Adjuvant Effect Compared with MF59.Pre-erythrocytic malaria vaccines: identifying the targets.Cationic lipid/DNA complexes (JVRS-100) combined with influenza vaccine (Fluzone) increases antibody response, cellular immunity, and antigenically drifted protectionSingle- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets.Chemical cross-linking of HIV-1 Env for direct TLR7/8 ligand conjugation compromises recognition of conserved antigenic determinantsThe adjuvant MF59 induces ATP release from muscle that potentiates response to vaccinationIn vitro responses to avian influenza H5 by human CD4 T cellsInnate immune control of nucleic acid-based vaccine immunogenicity.The ABC of clinical and experimental adjuvants--a brief overview.Human influenza vaccines and assessment of immunogenicity.Combination adjuvants: the next generation of adjuvants?Trends in vaccine adjuvants.Adjuvants for enhancing the immunogenicity of whole tumor cell vaccines.
P2860
Q27007659-92813874-A283-489C-96D0-6D2833E83C18Q27304934-D17C2CA5-71E6-41D4-A4AA-983765774AB5Q28552440-687145EB-7ED4-4F8E-B327-53AD48FC6F3FQ28741710-1300083B-BC34-40C1-A28B-76A04CA343C8Q28748680-8D403CED-4512-42E6-9EAA-90DA377C0608Q30352121-EF79FA9F-89A2-4427-AFEC-820CD7FBE5B9Q30370898-715D2B10-F8EB-496E-9E92-36007B0E636CQ30373784-0F64F647-FAAD-40FD-B1B9-50A2D6A2A975Q30375985-E569315D-F283-44D6-B069-1D0ED903B7ACQ30390234-0F126FA1-6D3A-493F-80D9-26B0869DAA81Q30402018-7036B984-395F-44AE-9A88-18906792DFE2Q30407424-BD96A894-CFDD-445C-88FD-35CD4D00DEC8Q30436915-1D20D16B-A054-4DED-B439-3703BF7208E1Q33451335-3BAC7064-761A-49E2-8B0D-E5B7FBB5112BQ33621078-6EB476CB-0A8B-4AFE-9B01-BC751C1BB2A0Q33623351-D4C3CD93-FA35-463F-9299-B4AAF5747AD4Q33673210-1D11604D-349C-4DC4-B882-8A08242BE750Q33901007-BCFC5C70-0E8B-4090-B644-7D1B1960E046Q34033780-E139ED64-F9E4-49CE-97BB-A4085236C547Q34113328-4B28175A-3B2C-40C4-81DB-A5B21CAB657EQ34144218-F1944F4F-81E3-49B8-A944-6FEA504D432FQ34582628-56C27CF3-EF12-4E86-851C-1881A3037D1FQ34584142-46A1DDD7-6F99-4957-A0A7-2ECA6C64364CQ35192675-88015486-8AF0-4D19-943D-E7C0E9A8E690Q35826767-F55473D8-F355-455C-9170-A545C9517D90Q35874111-A1358D0E-AF52-4EA1-BB69-47656327F8EFQ36021357-9BD376CC-1FB6-41FC-A5A7-9AA7DF923D96Q36239573-035EEEEF-1CC1-4348-88D4-9CCB72E8A6E5Q36644236-D0428D00-0591-4C4C-93BF-39ADBF6278E0Q37212827-F6671BD1-A38A-4E47-A511-DCBEAAAD8BEFQ37223707-84A5EE16-F5CF-416C-9A48-35E209736835Q37240218-6C718113-650D-489C-9390-56F5DD56DE47Q37421379-C6773BEF-3508-48FA-B18E-DD5376E015CCQ37439507-DCEDCF11-F9A1-47AB-8DAF-1DB3C1871D84Q37559651-4923C990-A7D9-424D-8DFE-B24ACA17BBFCQ37628867-532F1EA1-888E-40CB-A470-60F5DDAC3929Q37812125-023102BE-786C-4AD0-BC1F-72A6764496D0Q37821483-C47F6AD2-DCE3-4D2B-B592-E2B5367A170CQ37867107-AB803794-D996-43D0-BC3F-C6CF1FF5F488Q37873932-425B20DD-D801-402C-AB7B-F2F3C4D06DA3
P2860
Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Combination adjuvants for the ...... to influenza vaccine in mice.
@ast
Combination adjuvants for the ...... to influenza vaccine in mice.
@en
type
label
Combination adjuvants for the ...... to influenza vaccine in mice.
@ast
Combination adjuvants for the ...... to influenza vaccine in mice.
@en
prefLabel
Combination adjuvants for the ...... to influenza vaccine in mice.
@ast
Combination adjuvants for the ...... to influenza vaccine in mice.
@en
P2093
P50
P1433
P1476
Combination adjuvants for the ...... to influenza vaccine in mice.
@en
P2093
Anne K Hilbert
Barbara C Baudner
Derek T O'Hagan
Giuseppe Del Giudice
Hanno Scheffczik
Ilaria Manini
Jina Kazzaz
Manmohan Singh
Mildred Ugozzoli
Sandra Nuti
P304
P356
10.1016/J.VACCINE.2007.11.054
P407
P577
2007-12-07T00:00:00Z